BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2008
View Archived Issues
FDA assigns priority review status to sanofi-aventis' NDA for Multaq in atrial fibrillation
Read More
Study examines role of insulin signaling in early Alzheimer's disease
Read More
Studies in vitro, in vivo display activity of gamma-secretase inhibitor GSI-953
Read More
Novel vitamin/nutriceutical formulation improves cognitive decline and behavioral symptoms
Read More
Mechanism of action discovered for the novel TNF-alpha production inhibitor SA-13353
Read More
Recent highlights at Elan
Read More
Cortex reports positive results from RD-02 phase IIa clinical trial of Ampakine in RD
Read More
Sound's chemoprotectant drug cleared for phase II hearing loss trial
Read More
Hematide phase III program cleared to continue by DMC
Read More
Metabasis and Roche collaborate in HCV
Read More
New data on TMC-278, a next-generation NNRTI, presented at the International AIDS Conference
Read More
Xanodyne reports positive results from two phase III clinical trials of tranexamic acid
Read More
Geron initiates enrollment in phase I/II clinical trial of GRN-163L in breast cancer
Read More
GTC Biotherapeutics submits final portion of BLA for ATryn to FDA
Read More
Innocoll completes dosing in phase II clinical trial of CollaRx in postoperative pain
Read More
Archemix and Ribomic sign license agreement for aptamers against multiple targets
Read More
FDA extends review timeline by 3 months for Centocor's BLA for ustekinumab
Read More
Lixte's compounds for brain tumors demonstrate activity in pancreatic cancer models
Read More
Good antiviral activity of Achillion's elvucitabine in phase II study
Read More
Novel JAK3 inhibitors described in patent literature
Read More
Novel agents for diagnosis of AD discussed in Nihon Medi-Physics patent
Read More
New agents for gastrointestinal disorders revealed in recent patents
Read More